Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Jun 15;14:3745–3755. doi: 10.2147/OTT.S289198

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2021 Wu et al.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

BTG2 is the target gene of miR-544b. (A) Prediction results of miR-544b target genes. (B) Enrichment analysis of miR-544b target gene. (C) Target site information of miR-544b and BTG2. (D) The binding of miR-544b to BTG2 was detected by reporter vector assay. (E) RNA pull down assay was used to detect the binding of miR-544b to BTG2. (F) Detection of BTG2 expression after different treatments. (G) Detection of BTG2 expression in tumors. (H) Correlation analysis between miR-544b and BTG2. **P<0.01.